● Recruiting

Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue

Condition: Traumatic Cartilage Injury · Sponsor: Chinese University of Hong Kong

PhasePhase 1

Planned participants9

Who can joinAll sexes, 18 Years to 60 Years

Healthy volunteersNo

About this study

The objective of the study is to establish the safety profile of the autologous engineered osteochondral tissues (eOCT) in treating traumatic chondral lesions in patients.

This description comes directly from the study's public registry record.

Talk to the study team

Barbara Pui CHAN, PhD · +852-3943-0509 · bpchan@cuhk.edu.hk

Yinan QIU, Master · +852-3943-0509 · ynqiu@cuhk.edu.hk

Always discuss trial participation with your own doctor first.

Locations (2)

Queen Elizabeth Hospital	Jordon, Hong Kong	Recruiting
Prince of Wales Hospital	Shatin, Hong Kong	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06400862